Evidence map›Paper›PMID 34419936›Full record

ArticleAging2021

LncRNA AC136007.2 alleviates cerebral ischemic-reperfusion injury by suppressing autophagy.

Na Liu, Aini Peng, Haiyan Sun, Yuansu Zhuang, Ming Yu, Qun Wang, Jinping Wang

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. ALDH2 activation attenuates oxygen-glucose deprivation/reoxygenation-induced cell apoptosis, pyroptosis, ferroptosis and autophagy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Dysregulation of mTOR Signaling after Brain Ischemia.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Na LiuDepartment of Neurology, The First People's Hospital of Zhenjiang, Zhenjiang 212000, Jiangsu Province, China.
Aini PengDepartment of Neurology, The First People's Hospital of Zhenjiang, Zhenjiang 212000, Jiangsu Province, China.
Haiyan SunDepartment of Neurology, Jilin Provincial FAW General Hospital, Changchun 130000, Jilin Province, China.
Yuansu ZhuangDepartment of Neurology, The First People's Hospital of Zhenjiang, Zhenjiang 212000, Jiangsu Province, China.
Ming YuDepartment of Neurology, Affiliated Hospital of Jiangsu University, Zhenjiang 212000, Jiangsu Province, China.
Qun WangDepartment of Neurology, The First People's Hospital of Zhenjiang, Zhenjiang 212000, Jiangsu Province, China.
Jinping WangDepartment of Neurology, The First People's Hospital of Zhenjiang, Zhenjiang 212000, Jiangsu Province, China.
Central People's Hospital of Zhanjiang · CNZhenjiang City Fourth People's Hospital · CNAffiliated Hospital of Jiangsu University · CNJiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differential expression and diagnostic significance of the long noncoding RNA (lncRNA) AC136007.2 has been reported in patients with acute ischemic stroke (AIS). However, its role on disease progression and outcome remains unclear. Here, we employed an oxygen-glucose deprivation/reperfusion (OGD/R) model in neuronal SH-SY5Y cells and performed middle cerebral artery occlusion (MCAO) surgery in rats to investigate the function of AC136007.2 in ischemia-reperfusion (I/R) injury. AC136007.2 expression was determined by RT-qPCR and cell viability was examined using CCK-8, Edu, LDH, and apoptosis assays. Pro-inflammatory cytokine expression was assessed using ELISA. OGD/R downregulated AC136007.2 expression in SH-SY5Y cells, decreased viability by inducing apoptosis, and stimulated secretion of TNF-α, IL-6, and IL-1β. In turn, lentivirus-mediated AC136007.2 overexpression significantly reversed these phenomena. LC3 immunofluorescence and western blotting analyses of LC3-I/II and Beclin-1 expression and AMPK/mTOR phosphorylation status showed that AC136007.2 suppressed autophagy in SH-SY5Y cells via inactivation of AMPK/mTOR signaling. Notably, incubation with the AMPK activator AICAR abolished the pro-survival effect of AC136007.2 upon OGD/R treatment. Importantly, intraventricular injection of AC136007.2 significantly reduced cerebral infarction and brain edema in MCAO rats, as shown by TTC staining and water content measurements. We conclude that AC136007.2 alleviates cerebral I/R injury by suppressing AMPK/mTOR-dependent autophagy.

Indexed as

Neuroprotective AgentsAnimalsApoptosisAutophagyCell SurvivalGlucoseInfarction, Middle Cerebral ArteryMaleOxygenRatsRats, Sprague-DawleyReperfusion InjuryRNA, Long NoncodingSignal TransductionGlucoseNeuroprotective AgentsOxygenRNA, Long Noncodingautophagyischemic strokelncRNAMCAOOGD/R

Identifiers

PMID34419936
PMCPMC8386572
OpenAlexW3195712333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.